Enhancing Motor Learning in Children With Cerebral Palsy Using Transcranial Direct-current Stimulation
NCT ID: NCT04725019
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2021-08-01
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)
NCT01852474
Single-session tDCS in Cerebral Palsy
NCT03635775
A Study on Safety of tDCS One-shot in UCP
NCT03137940
tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
NCT03402854
Strength Training Using Neuromuscular Electrical Stimulation For Children With Cerebral Palsy
NCT00356343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS + motor training
In this arm, participants will receive 20 minutes of active tDCS and motor training that involves a high number of repetitions while engaged in child-friendly games.
Motor training
Participants will engage in a high number of repetition of movements that use both hands while playing with toys and games. Training will be provided 20 min/day, for 5 consecutive days.
active transcranial direct current stimulation
Participants will receive 20 min of tDCS over the scalp during 20 min of motor training.
Sham tDCS + motor training
In this arm, participants will receive 20 minutes of sham tDCS and motor training that involves a high number of repetitions while engaged in child-friendly games. Children receiving sham tDCS will wear the tDCS device but not receive active stimulation.
Motor training
Participants will engage in a high number of repetition of movements that use both hands while playing with toys and games. Training will be provided 20 min/day, for 5 consecutive days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motor training
Participants will engage in a high number of repetition of movements that use both hands while playing with toys and games. Training will be provided 20 min/day, for 5 consecutive days.
active transcranial direct current stimulation
Participants will receive 20 min of tDCS over the scalp during 20 min of motor training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* True positive response on the Transcranial Magnetic Stimulation and MRI Safety Screen
* Current use of medications known to lower the seizure threshold
* Previous episode of unprovoked neurocardiogenic syncope
* Indwelling metal or incompatible medical devices
* Centrally-acting medications including anti-seizure medications
* Evidence of scalp disease or skin abnormalities
* Current medical illness unrelated to CP
* High motor ability in affected arm (i.e. no asymmetry in scores of hand function)
* Severe spasticity
* Lack of asymmetry in hand function
* Orthopedic surgery in affected arm
* Botulinum toxin therapy in either upper extremity during last 6 months, or planned during study period
* Currently receiving intrathecal baclofen
* History of broken arm (either arm) 1 year prior to study enrollment
6 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston University Charles River Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudio
Assistant Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5825
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.